Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.00
Bid: 77.00
Ask: 77.30
Change: -0.20 (-0.26%)
Spread: 0.30 (0.39%)
Open: 76.60
High: 77.15
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment totalling c. GBP 9.9 million

20 Mar 2015 15:29

RNS Number : 0874I
GCP Infrastructure Investments Ltd
20 March 2015
 



20 March 2015



GCP Infrastructure Investments Limited

("GCP" or "the Company")

Investment totalling c. £9.9 million

 

GCP, the only listed fund focused on investments in UK infrastructure debt, is pleased to announce the completion of a hydro-electric transaction subscribing for loan notes with a term of c.18 years and an aggregate value of c. £9.9 million (the "Notes").

The Notes will be issued by GCP Hydro 1 Limited, a single purpose company, and the proceeds from the issue of the Notes will be used to make two loans secured on a senior basis to finance the construction of two hydro-electric schemes, one 1.9 MW and one 0.9 MW, in Scotland.

Following the commissioning of the plants, all payments of both principal and interest in relation to the Notes are expected to be serviced from income arising under the UK Government's Feed-In Tariff Scheme.

The acquisition of the Notes has been financed from available cash reserves.

Contact details:

 

 

 

Gravis Capital Partners LLP

 

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

 

 

Stifel Nicolaus Europe Limited

 

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

 

Tunga Chigovanyika

 

 

 

Cenkos Securities plc

 

Dion Di Miceli

+44 (0)20 7397 1921

Tom Scrivens

+44 (0)20 7397 1915

 

 

Buchanan

 

Charles Ryland

+44 (0)20 7466 5000

Sophie McNulty

 

 

 

 

Notes to Editors

The Company

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

The Projects

The projects will be two medium sized (1.9MW and 0.9MW) run of river Hydropower schemes located in Scotland. They will benefit from payments for the electricity generated under the UK Government's Feed-In Tariff Schemeat a generation tariff of 13.03p per kWh and in addition are able to sell the electricity generated to the market under a separate power purchase agreement.

The Feed-In Tariff Scheme

The Feed-In Tariff scheme was introduced by the UK Government with effect from April 2010 to encourage the use of energy in the UK from renewable sources (including hydropower). The scheme guarantees to electricity producers a fixed price for electricity produced from renewable sources for a term of 20 years, inflating at RPI.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDXIDDBGUG
Date   Source Headline
18th Sep 20235:23 pmRNSTransaction in Own Shares
18th Sep 20237:02 amRNSCessation of combination discussions
7th Sep 20235:23 pmRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTermination of Discussions with RMII
4th Sep 20235:16 pmRNSTransaction in Own Shares
1st Sep 20235:20 pmRNSTransaction in Own Shares
1st Sep 20234:00 pmRNSQuotedData's Weekly News & Interview
31st Aug 20235:25 pmRNSTotal Voting Rights
24th Aug 20235:24 pmRNSTransaction in Own Shares
23rd Aug 20235:22 pmRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSQuarterly investor update
22nd Aug 20235:54 pmRNSTransaction in Own Shares
21st Aug 20235:34 pmRNSTransaction in Own Shares
21st Aug 20239:30 amRNSUpdate from QuotedData
18th Aug 20235:25 pmRNSTransaction in Own Shares
17th Aug 20235:05 pmRNSTransaction in Own Shares
16th Aug 20235:33 pmRNSTransaction in Own Shares
15th Aug 20235:29 pmRNSTransaction in Own Shares
11th Aug 20235:20 pmRNSTransaction in Own Shares
11th Aug 20237:00 amRNSProposed Combination
31st Jul 202310:03 amRNSTotal Voting Rights
28th Jul 20237:00 amRNSDividend Declaration
28th Jul 20237:00 amRNSCompany update and net asset value
21st Jul 20235:19 pmRNSTransaction in Own Shares
21st Jul 20233:20 pmRNSDirector/PDMR Shareholding
18th Jul 20235:24 pmRNSTransaction in Own Shares
17th Jul 20235:34 pmRNSTransaction in Own Shares
14th Jul 20235:24 pmRNSTransaction in Own Shares
30th Jun 20235:53 pmRNSTotal Voting Rights
21st Jun 20235:16 pmRNSTransaction in Own Shares
21st Jun 20237:00 amRNSHalf-yearly report and financial statements 2023
19th Jun 20235:15 pmRNSTransaction in Own Shares
15th Jun 20235:14 pmRNSTransaction in Own Shares
14th Jun 20235:22 pmRNSTransaction in Own Shares
12th Jun 20235:17 pmRNSTransaction in Own Shares
6th Jun 20235:32 pmRNSTransaction in Own Shares
31st May 20235:38 pmRNSTotal Voting Rights
31st May 20235:35 pmRNSTransaction in Own Shares
26th May 20234:28 pmRNSTransaction in Own Shares
24th May 202312:17 pmRNSTransaction in Own Shares
23rd May 20235:18 pmRNSTransaction in Own Shares
22nd May 20232:21 pmRNSCompliance with Market Abuse Regulation
19th May 20234:54 pmRNSTransaction in Own Shares
18th May 20235:26 pmRNSTransaction in Own Shares
16th May 20235:10 pmRNSTransaction in Own Shares
15th May 20237:00 amRNSPortfolio Update
12th May 20235:11 pmRNSTransaction in Own Shares
11th May 20235:08 pmRNSTransaction in Own Shares
9th May 20237:00 amRNSQuarterly investor update
4th May 20235:46 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.